Intensity Modulated Proton Therapy After Surgery for the Treatment of Head and Neck Cancer, the HEADLIGHT Study
Conditions: Head and Neck Carcinoma; Head and Neck Carcinoma of Unknown Primary; Hypopharyngeal Carcinoma; Laryngeal Carcinoma; Metastatic Malignant Neoplasm in the Lymph Nodes; Nasal Cavity Carcinoma; Oral Cavity Carcinoma; Oropharyngeal Carcinoma; Paranasal S inus Carcinoma; Salivary Gland Carcinoma; Skin Carcinoma Interventions: Drug: Cisplatin; Procedure: Intensity-Modulated Proton Therapy; Other: Quality-of-Life Assessment; Other: Questionnaire Administration Sponsors: Mayo Clinic; National Cancer Institute (NCI) Not yet recruiti...
Source: ClinicalTrials.gov - October 13, 2021 Category: Research Source Type: clinical trials